February 2026

Hormone therapy may not benefit most men receiving radiotherapy after prostate surgery, study finds

by University of California, Los Angeles edited by Gaby Clark, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Credit: Marta Branco from Pexels A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that adding hormone therapy to postoperative radiotherapy may provide little survival benefit for most men with prostate cancer, […]

Hormone therapy may not benefit most men receiving radiotherapy after prostate surgery, study finds Read More »

Why liver congestion turns dangerous: A newly mapped pathway to fibrosis and cancer

by University of Osaka edited by Stephanie Baum, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Mechanical responses of liver sinusoidal endothelial cells to hepatic congestion. Credit: Seiya Kato The long-term stasis of blood in the liver, known as chronic liver congestion, can lead to a range of diseases, some of which are fatal.

Why liver congestion turns dangerous: A newly mapped pathway to fibrosis and cancer Read More »

A potential immunotherapy strategy for early-stage prostate cancer

by Jessica Saenz, Mayo Clinic edited by Lisa Lock, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Credit: Cell Reports Medicine (2026). DOI: 10.1016/j.xcrm.2026.102638 Immunotherapy has been generally ineffective for prostate cancer because the tumors are considered immunologically “cold,” meaning they do not attract enough immune cells to mount a strong attack. Hormone therapy commonly used

A potential immunotherapy strategy for early-stage prostate cancer Read More »

Novel delivery method bypasses blood-brain barrier to treat ALS symptoms

by Brian Consiglio, University of Missouri edited by Gaby Clark, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source TLN treatment sustains cholinergic synaptic inputs and mitochondria functionality in vivo. Credit: Advanced Science (2026). DOI: 10.1002/advs.202514128 A researcher at the University of Missouri has made a promising breakthrough in the quest to help people with amyotrophic lateral

Novel delivery method bypasses blood-brain barrier to treat ALS symptoms Read More »

How to protect your skin from UV damage for as little as $40 a year

by University of California, San Francisco edited by Stephanie Baum, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Credit: Mikhail Nilov from Pexels Consumers can protect their skin from damaging ultraviolet (UV) light rays for as little as $40 a year—or as much as $1,400 a year—depending on how expensive a sunscreen they buy

How to protect your skin from UV damage for as little as $40 a year Read More »

FDA approves Dupixent for allergic fungal rhinosinusitis

by Lori Solomon edited by Stephanie Baum, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult and pediatric patients aged 6 years and older with allergic fungal rhinosinusitis (AFRS) and a history of sino-nasal surgery. Dupixent received priority review

FDA approves Dupixent for allergic fungal rhinosinusitis Read More »

If you’re struggling to lose weight, could chilling your carbs help?

by J.m. Hirsch edited by Alexander Pol  Editors’ notes  The GIST Add as preferred source Grains of uncooked jasmine rice appear in Harrisburg, Pa., on April 24, 2008. Credit: AP Photo/Carolyn Kaster, File Online influencers claim the secret to low-calorie rice, pasta and potatoes may be as simple as chilling out. Are they right? Not quite.

If you’re struggling to lose weight, could chilling your carbs help? Read More »

Patients with atrial fibrillation face higher bleeding risks when treated with 2 common medications

by Vanderbilt University Medical Center edited by Sadie Harley, reviewed by Andrew Zinin  Editors’ notes  The GIST Add as preferred source Credit: CC0 Public Domain Patients with atrial fibrillation who are prescribed diltiazem to control heart rate alongside anticoagulants (blood thinners) such as apixaban or rivaroxaban face a higher risk of serious bleeding compared with those taking metoprolol,

Patients with atrial fibrillation face higher bleeding risks when treated with 2 common medications Read More »

How Nighttime Light Quietly Became a Serious Health Threat

How often do you reach for your phone before bed and remember that blue light can disrupt your sleep, but you scroll on anyway? Yeah, us too. Over the past few years, separate research has linked nighttime light exposure to, yes, sleep disruption, but also negative effects on cardiac, metabolic, cognitive, and mental health. It’s

How Nighttime Light Quietly Became a Serious Health Threat Read More »

A promising new drug for an invasive type of breast cancer

by Ecole Polytechnique Federale de Lausanne edited by Sadie Harley, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Model of PXS-5505 in action. In the absence of CDH1 the deposition and sensing of matrix components via integrins compensates and controls key transcriptional mediators, LOX inhibition perturbs this signaling axis, resulting in signaling and cell

A promising new drug for an invasive type of breast cancer Read More »

Scroll to Top